Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders
- PMID: 26303310
- PMCID: PMC4624515
- DOI: 10.1111/nmo.12655
Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders
Abstract
Background: Gastrointestinal infections are risk factors for irritable bowel syndrome (IBS) and functional dyspepsia (FD). We investigated whether non-enteric infections and antibiotic exposure are also associated with the development of functional gastrointestinal disorders (FGIDs).
Methods: In a nested case-control study, random samples of Olmsted County, MN, were mailed valid self-report questionnaires from 1988 through 1994, and then follow-up questionnaires from 1995 through 2003. Survey responders who did not report any FGID symptoms at baseline, but then reported such symptoms in at least one subsequent survey, were classified as new-onset cases. Age-matched controls were individuals who did not have symptoms at either the initial or subsequent surveys.
Key results: The overall response rate was 78% to the initial survey and 52% to the follow-up survey. Based on the responses, 316 participants had a new onset of an FGID (43 IBS constipation, 95 IBS diarrhea, 25 IBS mixed, and 153 other FGIDs, including FD) and 250 did not (controls). Around 76% (241/316) of cases reported a non-enteric infection vs 66% (166/250) of the controls. The frequency of enteric infections was similar between the two groups. Of the new FGID cases, 83% had a non-enteric infection that was treated with antibiotic. In a logistic regression model, treatment with antibiotics for a non-gastrointestinal infection was associated with the development of an FGID (odds ratio = 1.90; 95% CI: 1.21-2.98; p = 0.005), after adjusting for age and sex.
Conclusions & inferences: Based on a case-control study, treatment of a non-gastrointestinal infection with antibiotics appears to be a risk factor for development of an FGID.
Keywords: antibiotics; functional GI disorders; irritable bowel syndrome; non-enteric infections.
© 2015 John Wiley & Sons Ltd.
Comment in
-
Antibiotic use and subsequent development of functional gastrointestinal disorders: effect of symptom-reporting and consultation behavior.Neurogastroenterol Motil. 2016 Mar;28(3):449-50. doi: 10.1111/nmo.12746. Neurogastroenterol Motil. 2016. PMID: 26891062 No abstract available.
-
Antibiotics and onset of functional gastrointestinal disorders.Neurogastroenterol Motil. 2016 Mar;28(3):451. doi: 10.1111/nmo.12781. Neurogastroenterol Motil. 2016. PMID: 26891063 No abstract available.
Similar articles
-
Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S138-43. doi: 10.1111/j.1440-1746.2010.06244.x. J Gastroenterol Hepatol. 2010. PMID: 20586856
-
The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.J Dig Dis. 2014 Oct;15(10):538-44. doi: 10.1111/1751-2980.12178. J Dig Dis. 2014. PMID: 25102919
-
Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study.Am J Gastroenterol. 2003 Sep;98(9):1970-5. doi: 10.1111/j.1572-0241.2003.07664.x. Am J Gastroenterol. 2003. PMID: 14499773
-
Definition and epidemiology of functional gastrointestinal disorders.Best Pract Res Clin Gastroenterol. 2004 Aug;18(4):613-31. doi: 10.1016/j.bpg.2004.04.012. Best Pract Res Clin Gastroenterol. 2004. PMID: 15324703 Review.
-
STW 5 (Iberogast) Therapy in Gastrointestinal Functional Disorders.Dig Dis. 2017;35 Suppl 1:25-29. doi: 10.1159/000485410. Epub 2018 Feb 8. Dig Dis. 2017. PMID: 29421817 Review.
Cited by
-
Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders.Biol Sex Differ. 2022 Mar 25;13(1):12. doi: 10.1186/s13293-022-00422-6. Biol Sex Differ. 2022. PMID: 35337376 Free PMC article. Review.
-
Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation.mSystems. 2021 Dec 21;6(6):e0121521. doi: 10.1128/mSystems.01215-21. Epub 2021 Nov 2. mSystems. 2021. PMID: 34726487 Free PMC article.
-
Microbiome and Its Role in Irritable Bowel Syndrome.Dig Dis Sci. 2020 Mar;65(3):829-839. doi: 10.1007/s10620-020-06109-5. Dig Dis Sci. 2020. PMID: 32026278 Review.
-
New and Investigational Agents for Irritable Bowel Syndrome.Curr Gastroenterol Rep. 2015 Dec;17(12):46. doi: 10.1007/s11894-015-0473-x. Curr Gastroenterol Rep. 2015. PMID: 26446557 Review.
-
Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders.United European Gastroenterol J. 2021 Nov;9(9):1074-1080. doi: 10.1002/ueg2.12164. Epub 2021 Oct 15. United European Gastroenterol J. 2021. PMID: 34653313 Free PMC article.
References
-
- Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–1390. - PubMed
-
- Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ., 3rd Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102:1259–1268. - PubMed
-
- Parry S, Forgacs I. Intestinal infection and irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2005;17:5–9. - PubMed
-
- Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008;20(Suppl 1):121–129. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical